Monday 20 November 2017

Brady to leave top job at Lloyds pharmacy chain in March

Goretti Brady, managing director of Lloyds, oversaw the chain’s aggressive expansion plan Picture: Aidan Crawley
Goretti Brady, managing director of Lloyds, oversaw the chain’s aggressive expansion plan Picture: Aidan Crawley
Samantha McCaughren

Samantha McCaughren

Goretti Brady, managing director of the country's largest pharmacy chain Lloyds, is to leave the group in the coming weeks.

It is understood that Brady recently informed colleagues of her plans to leave the company in March.

She has been at the chain for over 16 years and held the top job for almost four years, driving the chain's aggressive expansion plan.

Brady leaves as a time of immense change at the company, which is now owned by US pharmacy giant McKesson. In September 2015, McKesson agreed to pay €408m to acquire the Irish pharmaceutical distribution business UDG Healthcare.

The company is in the process of integrating the two firms and has ambitious plans to roll out new services in the coming years.

In 2015, Lloyds was hit by a controversy over the level of dispensing fees being claimed by the pharmacy chain. Last year, Lloyds settled with the HSE.

Brady, a qualified pharmacist from Castlerea, Co Roscommon, previously worked as director of marketing and sales for the chain, which was formerly known as Unicare and briefly as Doc Morris before being rebranded as Lloyds.

The group has over 90 stores and Brady had ambitions to expand it to over 150 shops. She ran the rule over dozens of potential acquisitions.

At one point the company was in talks to takeover Sam McCauleys, an Irish-owned chain with 30 stores. However the deal did not proceed. She also oversaw a period of significant investment in the chain.

Sunday Indo Business

Promoted Links

Promoted Links

Business Newsletter

Read the leading stories from the world of Business.

Also in Business